Define Classification & Approach to a Bone Tumour. Describe its clinical features and management.

Definition & Importance

Bone tumours are neoplasms arising in bone; they may be primary (from bone-forming, cartilage-forming, fibrous or marrow cells) or secondary (metastatic), and benign or malignant. Primary bone tumours are relatively rare, but early recognition matters because a missed malignancy loses the window for limb-salvage and cure, whereas an unnecessary aggressive biopsy of a benign lesion causes harm. A logical, staged approach is therefore essential.

Assessing a Bone Lesion

Assessment integrates age (each tumour has a typical age range), the bone and the site within it (epiphysis vs metaphysis vs diaphysis), the clinical picture, and the radiographic character. Key radiographic questions define aggressiveness: the zone of transition (narrow/sclerotic = benign; wide/permeative = aggressive), the pattern of bone destruction (geographic vs moth-eaten vs permeative), the periosteal reaction (solid = benign; interrupted ‘sunburst’, ‘onion-skin’ or Codman’s triangle = aggressive), and any soft-tissue mass or matrix mineralisation.

Clinical Features Suggesting Malignancy

Warning features are progressive deep-seated pain (often worse at night and unrelated to activity), a enlarging mass, a pathological fracture through a lesion, and constitutional symptoms. Any persistent unexplained bone pain, particularly around the knee in a young person, warrants a radiograph.

Investigations & Staging

• Plain radiographs in two planes are the essential first step.
• MRI defines intramedullary and soft-tissue extent and the relationship to neurovascular structures
• CT chest detects pulmonary metastases
• a bone scan / pet assesses skeletal spread. The definitive diagnosis rests on biopsy. Malignant tumours are staged by the Enneking (Musculoskeletal Tumour Society) system, which combines grade (low I / high II), compartment status (intra- A / extra-compartmental B) and the presence of metastases (III).

Principles of Management

Benign lesions are observed or treated by curettage/excision as needed. Malignant tumours are managed by a multidisciplinary team with a combination of surgery (wide local excision with limb-salvage where possible, or amputation), chemotherapy (neoadjuvant and adjuvant for osteosarcoma and Ewing’s) and radiotherapy (central to Ewing’s, adjunctive in others), tailored to tumour type, grade and stage.

The Biopsy — Principles

Biopsy is the definitive diagnostic step but is fraught with pitfalls. Whether by needle (core) or open (incisional) technique, it must be performed or directed by the surgeon who will carry out the definitive resection. The tract is placed in line with the planned excision so it can be removed en bloc, avoids contaminating neurovascular structures or separate compartments, and takes representative tissue from the growing edge rather than a necrotic centre. A carelessly placed biopsy can seed tumour and compromise limb salvage.

Biopsy tract must be excisable at definitive surgery.

• Classify by tissue of origin and benign vs malignant; metastasis is the commonest bone malignancy.
• Integrate age, site, clinical picture and radiographic aggressiveness.
• Aggressive signs: wide zone of transition, cortical destruction, interrupted periosteal reaction, soft-tissue mass.
• Stage malignant tumours by Enneking (grade, compartment, metastasis); biopsy is definitive.
• Malignant tumours need MDT care: surgery ± chemotherapy ± radiotherapy; plan the biopsy carefully.